Power of Three

It’s been suggested that things that come in threes have a unique power and effect. We agree. Our viral immunotherapies pack a powerful trio of attributes – and the potential to transform outcomes for cancer patients.
Selective Attack

Our viral immunotherapies are designed to selectively attack tumor cells.

Read More
Potent Destruction

Our viral immunotherapies are designed to potently destroy tumors from within.

Read More
Broad Immune Stimulation

Our viral immunotherapies are designed to simultaneously stimulate multiple arms of the immune system to maximize a systemic anti-tumor response.

Read More

Expansive Reach with Two

Different types of cancer at different stages require distinct treatment strategies. Our dual-platform approach gives us the potential to treat a broad range of cancers.

About Synthetic vRNA Immunotherapy

Combining oncolytic viruses with an RNA-based approach to fight cancer

Motivated By One

For our team, the fight against cancer is personal.

We all have known someone who courageously fought a battle against cancer. Our personal stories motivate us each day in our pursuit of new, more effective cancer treatments
Explore our Pipeline
Pipeline Stages: Research, IND Enabling, Phase 1, Phase 2, Phase 3
ONCR-177
In stage: Phase 1
ONCR-GBM
In stage: Research
ONCR-021
In stage: IND Enabling
ONCR-788
In stage: IND Enabling

Get To Know Oncorus

WE ARE A GREAT COMPANY.

We work hard, together – because we care deeply, and we know that every day a patient goes without an effective treatment is one day too many. We also have fun – because the work we do is hard.
Learn More

News

Read All